LOXiGen ApS: Financial statements 2020
CVR: 41202793
Source: annual report 2020, Danish Business Authority
28/02/2020 – 31/12/2020
LOXiGen ApS (CVR 41202793) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -25,200 and a net result of DKK -25,200. Equity in the 2020 report amounted to DKK 14,800. The solvency ratio was 38.9%.
- Gross Profit
- DKK -25,200
- Profit/Loss
- DKK -25,200
- Equity
- DKK 14,800
- Total Assets
- DKK 38,000
- Employees
- 0
Official annual report
How creditworthy is LOXiGen ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of February 28, 2020, Janine Terra Erler is registered as director of LOXiGen ApS.
LOXiGen ApS was founded on February 28, 2020.
About LOXiGen ApS
LOXiGen ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2020. The company has been dissolved on 30 June 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2021 annual report, the company had an average of 0 employees. In 2021, the company reported a gross profit of DKK -8,575 and a net result of DKK -8,842 compared with DKK -25,200 the year before. Equity in the 2021 report amounted to DKK 5,958.